Peer-reviewed article
Testing Children for Adult-Onset Genetic Diseases
* Abbreviations: AAP — : American Academy of Pediatrics APC — : adenomatous polyposis coli BRCA1 and BRCA2 — : breast cancer–associated genes 1 and 2 FAP — : familial adenomatous polyposis HBOC syndrome — : hereditary breast and…
* Abbreviations: AAP — : American Academy of Pediatrics APC — : adenomatous polyposis coli BRCA1 and BRCA2 — : breast cancer–associated genes 1 and 2 FAP — : familial adenomatous polyposis HBOC syndrome — : hereditary breast and ovarian cancer syndrome
The Committee on Bioethics of the American Academy of Pediatrics (AAP) advises against genetic testing of children for conditions that have their onset in adulthood. They write, “Genetic testing for adult-onset conditions generally should be deferred until adulthood or until an adolescent interested in testing has developed mature decision-making capacities.”1 The Clinical Genetics Society in the United Kingdom expresses similar views, writing that “The predictive genetic testing of children…for an adult onset disorder should generally not be undertaken…until the ‘children’ request such tests for themselves, as autonomous adults.”2
Nevertheless, many parents seek genetic testing of their children, especially for situations in which a genetic disease is known to be present in the family. They may have different reasons for wanting their children tested. These requests create a dilemma for pediatricians. The dilemmas arise, in part, because not all “adult-onset” diseases are alike. Sometimes, there are interventions that may be beneficial in childhood; sometimes, parents seek the reassurance that might come with a negative test result.
When, if ever, should we accede to parents’ requests to test a child for an adult-onset condition? In this “Ethics Rounds,” we present 2 cases that illustrate the dilemma. We then ask experts in genetics and bioethics to comment on the cases and suggest the factors that pediatricians should consider when facing requests from parents for genetic testing of children.
### Case 1
A woman with familial adenomatous polyposis (FAP) contacted a genetic counselor to request genetic testing for her newborn infant. FAP is an autosomal-dominant, hereditary colon cancer syndrome caused by mutations in the adenomatous polyposis coli ( APC ) gene. Affected individuals generally begin to develop precancerous polyps as teenagers, although some have developed polyps as early as age 7. Colon cancer is inevitable, and the average age of colon cancer diagnosis in untreated individuals is …
Address correspondence to John D. Lantos, MD, Children’s Mercy Hospitals and Clinics, 2401 Gillham Rd, Kansas City, MO 64108. E-mail: jlantos{at}cmh.edu
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
Associations of Physician Perspectives, Personal Choices, and Counseling for Severe Congenital Heart Defects
OBJECTIVE: To assess whether physicians' perspectives of outcomes or personal choices are associated with prenatal counseling for termination of pregnancy (TOP) or perinatal hospice for severe congenital heart defects (CHDs). METHOD:…
Variation in the extent to which patient information leaflets describe potential benefits and harms of trial interventions: a commentary
Clinical trial participants must understand the possible risks and benefits of trial interventions before providing their informed consent to participate. The aim of this commentary is twofold: to summarize the discrepancies in the extent…
Pediatric Gender Medicine—Reply
Third, emerging evidence suggests that modulating glycosylation pathways could offer a novel therapeutic strategy for asthma management.Xie et al 5 proposed that targeting glycan recognition receptors, such as sialic acid-binding…
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.